About 500 Mcg Darbepoetin Alfa Injection
Experience the sizzling efficacy of 500 Mcg Darbepoetin Alfa Injection-an in-demand, ephemeral treatment crafted for those confronting anemia associated with chronic renal failure and chemotherapy. Its breathtaking purity (>98%) and phenomenal high bioavailability ensure optimal therapeutic outcomes. This lofty, prescription-only recombinant human erythropoietin, presented in a sterile pre-filled syringe, stimulates erythropoiesis efficiently. Clear and colorless, the solution is soluble in water, assuring ease of administration. Handled properly between 2C - 8C, it remains stable for up to 24 months. Suitable for adults, children, and the elderly, it stands as an outstanding solution distributed, exported, and supplied by reliable traders from India.
Who Uses 500 Mcg Darbepoetin Alfa Injection?
This injection is widely used by patients-adults, children, and elderly-battling anemia as a result of chronic renal failure or chemotherapy. Its specific use lies in stimulating red blood cell production, making it the general choice for those requiring erythropoiesis support. Typically prescribed by physicians, it accommodates broad suitability, ensuring targeted therapeutic action for diverse age groups.
Domestic Market Availability and Premium Packaging
The 500 Mcg Darbepoetin Alfa Injection is available across India at competitive sale prices suited to the domestic market's needs. Packaging is secured in a sterile pre-filled syringe, housed within a carton box to ensure integrity. The average rate reflects the product's high purity and safety. Samples may be available as per the supplier's policy, addressing client assurance and market adaptability.
FAQ's of 500 Mcg Darbepoetin Alfa Injection:
Q: How is 500 Mcg Darbepoetin Alfa Injection administered?
A: 500 Mcg Darbepoetin Alfa Injection is administered either subcutaneously (under the skin) or intravenously (into a vein), based on your physician's recommendation.
Q: What is the main benefit of using this injection for anemia?
A: The primary benefit is its ability to stimulate erythropoiesis-production of red blood cells-effectively helping manage anemia in patients with chronic kidney disease or those undergoing chemotherapy.
Q: Who should not receive this injection?
A: Individuals with uncontrolled hypertension or known hypersensitivity to Darbepoetin Alfa or its excipients should avoid this medication.
Q: When should this injection be used during treatment?
A: Your physician will determine the precise timing and frequency based on the severity of your anemia and your overall treatment plan.
Q: Where should this product be stored for safety?
A: Store the injection at 2C - 8C in a refrigerator. Do not freeze to maintain its stability and effectiveness for up to 24 months.
Q: What makes this injection different from other treatments for anemia?
A: It is a recombinant human erythropoietin with exceptional purity and high bioavailability, making it both potent and reliable for anemia management.